AAAAI 2015 Annual Meeting - Houston, TX
AAAAI 2015 Annual Meeting - Houston, TX

AAAAI 2015 Annual Meeting

February 20-24, Houston, Texas

Press Events

*All of the following press events will take place in the San Diego Convention Center, Mezzanine Level, Room 13.

Saturday, March 1
11:00 to 11:45 am
Research Highlights: Asthma, Rhinitis and Rhinosinusitis

Speakers:

  • Angelina M. Crans Yoon, MD
  • Cheryl S. Hankin, PhD
  • Kathryn E. Hulse, PhD
  • Jessica Rabe Savage, MD

Discussed Abstracts

Abstract 566 Urinary Levels Of Phytoestrogens Are Inversely Associated With Wheezing, Asthma, and Atopy
Abstract 579 Allergy Immunotherapy Significantly Reduces Outpatient Services Use for Allergy and Respiratory Conditions In Patients With Newly-Diagnosed Allergic
Abstract 584 Sex-Specific Differences In Disease Severity In Patients With Chronic Rhinosinusitis With Nasal Polyps
Abstract 811 Allergic Rhinitis, Asthma and Cardiovascular Disease

Sunday, March 2
11:00 to 11:45 am
Research Highlights: Food Allergy and Eosinophilic Esophagitis

Speakers:

  • A. Wesley Burks, MD, FAAAAI
  • Scott P. Commins, MD, PhD
  • Hugh A. Sampson, MD, FAAAAI
  • Jonathan M. Spergel, MD, PhD, FAAAAI

Discussed Abstracts

Abstract 360 Low Dose Maintenance Peanut Oral Immunotherapy Can Produce Sustained Unresponsiveness
Abstract 536 Length of Avoidance Period Following Peanut Oral Immunotherapy Influences Effector Cell Suppression and Clinical Outcomes
Abstract 990 Development of Eosinophilic Esophagitis To Food After Development of IgE Tolerance To The Same Food
Abstract L19 A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow’s Milk Allergy (CMA): Safety of Dosing

Monday, March 3
10:45 to 11:30 am
Choosing Wisely: Five More Things Physicians and Patients Should Question

Speakers:

  • Linda Cox, MD, FAAAAI; AAAAI President
  • Theodore M. Freeman, MD, FAAAAI
  • David M. Lang, MD, FAAAAI
  • John Oppenheimer, MD, FAAAAI

This press conference will unveil and discuss the AAAAI’s second list of “Five Things Physicians and Patients Should Question,” which is part of the ABIM Foundation’s Choosing Wisely initiative. The list of evidence-based recommendations is designed to help patients and physicians start conversations and make wise choices regarding the diagnosis and treatment of allergy, asthma and immunologic diseases.

What is Choosing Wisely?
The goal of Choosing Wisely is to increase conversation among physicians and patients concerning procedures and tests that have the potential to be used inappropriately.

In 2012, the AAAAI was one of nine medical organizations involved in the first round of developing lists of “Five Things Physicians and Patients Should Question.” You can read the AAAAI’s first Choosing Wisely list here.